STING Activates a New Necroptosis Pathway That Drives Inflammatory Skin Disease
A newly identified STING–ZBP1 necroptosis axis bypasses known death receptors and may explain hard-to-treat interferonopathies like SAVI.
Summary
Researchers at the University of Cologne discovered that STING, the innate immune DNA sensor, can trigger a lethal inflammatory cell death program called necroptosis through ZBP1 — entirely independently of the previously known TNFR1 and FADD death receptor pathways. Using caspase-8-deficient mice and cells, they showed that DNA accumulation activates STING, which upregulates ZBP1 and MLKL, forming a novel ZBP1–RIPK1–RIPK3 complex that executes necroptosis. This pathway was confirmed to drive pathology in SAVI, a rare human interferonopathy caused by gain-of-function STING mutations, and blocking RIPK3 rescued disease in the preclinical SAVI mouse model. The findings identify STING-driven ZBP1-mediated necroptosis as a central disease mechanism and a promising therapeutic target.
Detailed Summary
Necroptosis — a regulated, inflammatory form of cell death — has long been linked to tumor necrosis factor receptor 1 (TNFR1) signaling. Yet numerous genetic studies showed that removing TNFR1 fails to fully rescue inflammatory diseases driven by caspase-8 deficiency, hinting at alternative pathways. This landmark Nature paper identifies a previously uncharacterized axis: STING-activation-induced necroptosis (STAIN), mediated through Z-DNA-binding protein 1 (ZBP1), entirely independent of TNFR1 and FADD.
The team studied mice with conditional epidermal keratinocyte deletion of caspase-8 (Casp8-E-KO), which develop lethal necroptosis-driven dermatitis within the first postnatal week. Bulk RNA-sequencing of affected skin revealed a dominant interferon (IFN) response signature enriched for cytosolic DNA sensing and STING pathway genes. Histology confirmed elevated STING, phospho-STAT1, MLKL, and de novo ZBP1 expression in dying keratinocytes. Critically, treatment with the STING antagonist C-178 abolished ZBP1 upregulation and STAT1 activation in caspase-8-deficient mouse embryonic fibroblasts (MEFs), establishing that cytosolic DNA accumulation consequent to caspase-8 loss activates STING, which then drives an IFN-dependent transcriptional program upregulating both ZBP1 and MLKL.
Biochemical and genetic dissection revealed that STING activation promotes formation of a distinct ZBP1–RIPK1–RIPK3 necrosome complex, separate from the classical FADD–RIPK1–RIPK3 complex. In FADD-deficient and caspase-8-deficient cells, STING agonism drove ZBP1-dependent necroptosis even when FADD was absent, confirming true independence from the FADD axis. Blocking TNFR1 with etanercept did not prevent STING-induced necroptotic signaling, further validating the novel pathway's independence from canonical death receptor signaling.
The clinical relevance was established in STING-associated vasculopathy with onset in infancy (SAVI), a rare human disease caused by gain-of-function STING mutations. Patient samples showed a necroptotic transcriptional signature, and in the Sting1-N153S preclinical mouse model, immune-cell-driven pathology and lethality were significantly rescued by co-deletion of Ripk3 — demonstrating that necroptosis is a genuine driver rather than a bystander in SAVI pathogenesis.
These findings reframe our understanding of interferonopathy-associated inflammation. By showing that STING-driven ZBP1 activation is a discrete, therapeutically targetable necroptosis pathway, the study opens doors to new interventions for SAVI and other conditions characterized by chronic STING activation, including lupus, Aicardi–Goutières syndrome, and aging-associated sterile inflammation where cytosolic DNA accumulation is a known feature.
Key Findings
- Caspase-8 deficiency causes cytosolic DNA accumulation that aberrantly activates STING, driving IFN-dependent ZBP1 and MLKL upregulation.
- STING activation forms a novel ZBP1–RIPK1–RIPK3 necroptotic complex entirely independent of FADD and TNFR1.
- STING antagonism with C-178 abolishes ZBP1 expression and STAT1 phosphorylation in caspase-8-deficient cells.
- SAVI patients show a necroptotic transcriptional program; Ripk3 co-deletion rescues lethality in the Sting1-N153S SAVI mouse model.
- The STING–ZBP1–RIPK3–MLKL axis is identified as a central pathogenic mechanism in interferonopathy-driven inflammation.
Methodology
The study combined conditional keratinocyte-specific caspase-8 knockout mouse models with bulk 3′ RNA-sequencing, histology, co-immunoprecipitation, pharmacological STING agonism/antagonism, and multi-gene knockout MEF systems. Findings were validated in the Sting1-N153S SAVI mouse model and corroborated with transcriptional analysis of patient samples from SAVI-affected individuals.
Study Limitations
Most mechanistic work was conducted in immortalized MEFs, which may not fully recapitulate primary human cell biology. The SAVI patient transcriptomic analysis was correlative and limited in sample size. The relative contribution of keratinocyte-intrinsic versus immune-cell-driven STING-ZBP1 necroptosis in human disease remains to be quantified.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.